The importance of NFAT1 and NFAT1-MDM2 pathway in JapA's anti-breast cancer activity was further demonstrated using Tet-on inducible NFAT1 overexpression (OE) and siRNA NFAT1 knockdown (KD) MCF-7 cells. Here, NFATC2 is linked to breast carcinoma.